Dynavax Reports Comparable Immune Response of Shingles Vaccine
Dynavax Technologies Corporation has announced that its experimental shingles vaccine exhibited immune response levels comparable to those of GSK’s widely used vaccine, Shingrix, in the initial phase of a head-to-head…